TRPV1 Activation by Anandamide via a Unique Lipid Pathway

The capsaicin receptor, transient receptor potential vanilloid type 1 (TRPV1), is a polymodal channel that has been implicated in the perception of pain and can be modulated by a variety of cannabinoid ligands. Here we report TRPV1 channel activation by the endocannabinoid, anandamide (AEA), in a unique, peripheral binding site via extended MD simulations. These results aim to expand the understanding of TRPV1 and assist in the development of new TRPV1 modulators.

[1]  L. Petrocellis,et al.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain , 2006, Neuroscience.

[2]  Guonian Wang,et al.  Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain. , 2017, Molecular medicine reports.

[3]  P. Robson,et al.  Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine , 2007, Chemistry & biodiversity.

[4]  D. Lynch,et al.  A Closer Look at Anandamide Interaction With TRPV1 , 2020, Frontiers in Molecular Biosciences.

[5]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[6]  D. Julius,et al.  Structure of the TRPV1 ion channel determined by electron cryo-microscopy , 2013, Nature.

[7]  B. Wiese,et al.  Emerging Evidence for Cannabis' Role in Opioid Use Disorder , 2018, Cannabis and cannabinoid research.

[8]  H. Matzner,et al.  The pain receptor TRPV1 displays agonist-dependent activation stoichiometry , 2015, Scientific Reports.

[9]  P. Morales,et al.  Cannabinoid Ligands Targeting TRP Channels , 2019, Front. Mol. Neurosci..

[10]  D. McKemy,et al.  Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 , 2004, Nature.

[11]  M. Fitzcharles,et al.  Cannabis for chronic pain: case series and implications for clinicians. , 2002, Pain research & management.

[12]  D. Julius,et al.  The vanilloid receptor: a molecular gateway to the pain pathway. , 2001, Annual review of neuroscience.

[13]  D. Clapham,et al.  An introduction to TRP channels. , 2006, Annual review of physiology.

[14]  V. Di Marzo,et al.  Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens , 2001, British journal of pharmacology.

[15]  V. Di Marzo,et al.  Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels , 2010, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology.

[16]  D. Julius,et al.  TRPV1 structures in distinct conformations reveal mechanisms of activation , 2013, Nature.

[17]  D. Ponde,et al.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide , 2001, British journal of pharmacology.